University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Pediatr Dermatol. 2023 May-Jun;40(3):479-482. doi: 10.1111/pde.15269. Epub 2023 Feb 23.
Topical corticosteroids (TCS) are the most commonly prescribed treatment for children with atopic dermatitis and are supported by the American Academy of Dermatology (AAD) atopic dermatitis treatment guidelines with level I strength A evidence; however, fear regarding their use, coined "steroid phobia," is widespread. In this study, we analyzed steroid phobia-related content on popular social media platforms. We found much of this content consists of patients describing negative personal experiences with TCS and subsequently discouraging viewer use. We conclude that social media may contribute to steroid phobia, and we hope that our study motivates dermatologists with social media platforms to combat common misconceptions surrounding TCS use.
局部皮质类固醇（TCS）是治疗特应性皮炎儿童最常用的药物，得到了美国皮肤病学会（AAD）特应性皮炎治疗指南的支持，具有 I 级强度 A 证据；然而，人们对其使用的恐惧，即“皮质类固醇恐惧症”，却很普遍。在这项研究中，我们分析了流行社交媒体平台上与皮质类固醇恐惧症相关的内容。我们发现，这些内容大多是患者描述使用 TCS 后的负面个人经历，并劝阻观众使用。我们的结论是，社交媒体可能导致皮质类固醇恐惧症，我们希望我们的研究能激励拥有社交媒体平台的皮肤科医生，帮助消除围绕 TCS 使用的常见误解。
